Clinical Trials Directory

Trials / Completed

CompletedNCT03190161

Music to Reduce Use of Smoking in Patients With Schizophrenia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder who smoke/nicotine will participate in an individual session of self-selected music listening for a half an hour.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMusic sessionParticipants will be asked to refrain from smoking from 24 hours before the music listening session as confirmed by breath carbon monoxide level \<6 ppm on the day of the session. They will be contacted by phone or in person at the clinic as a reminder prior.

Timeline

Start date
2017-03-09
Primary completion
2018-09-17
Completion
2018-09-17
First posted
2017-06-16
Last updated
2019-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03190161. Inclusion in this directory is not an endorsement.